Life Science Analytics Market by Type (Descriptive, Prescriptive), Application (Marketing, R&D, Compliance, SCM), Component (Software, Service), Delivery (On premise, Cloud), End user (Pharmaceutical, Biotechnology, Medical Device, CRO) - Forecasts to 202
Life Science analytics market was valued at USD 13.24 billion in 2016 and is projected to reach USD 40.09 billion by 2025, growing at a CAGR of 13.1% from 2017 to 2025.
(EMAILWIRE.COM, April 04, 2018 ) Life Science Analytics Market analysis and trends expected to grow with CAGR of 13.1% from 2017 to 2025
“ By Type (Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, SCM), Component (Software, Service), Delivery (on premise, cloud) and End user (Pharmaceutical, Biotechnology, Medical Device, CRO), and Region (North America, Asia Pacific, Europe, Latin America, Rest of the World) Market Size, Status and Forecast to 2025.”
Market Definition:
Life science analytics software is majorly utilized by Pharmaceutical companies because of them facing unpredictable demands, depleting operating margins and increasing regulatory scrutiny. Inadequate visibility across the supply chain is hampering optimal performance as global sourcing increases the risk of longer lead times.
The growing complexity of operations results in the need to increase agility by improving supply chain visibility. Life science analytics provides the solution for the rising demands and management.
Companies Profiled in this report includes:IBM Corporation (U.S.), Oracle Corporation (U.S.), Quintiles, Inc. (U.S.), Accenture (Ireland), Cognizant (U.S.), Wipro Limited (India), MaxisIT, Inc. (U.S.), TAKE Solutions (India), and SCIO Health Analytics (U.S.).
>> Click here to Download Sample PDF illustration: http://bit.ly/2CBpcoF
Life science institutes and industries are adopting digital records due to their ease of integration, higher standardization, sophistication, and minimized errors. For instance, the health care industry is moving at a greater pace due to EHR (Electronic Health Records) which follow a standard format. The personal property security (PPSA) regulation influences pharmaceutical industries or firms to bring about easy analysis of market expenditure and competitor data to gain significant insights, as it allows data collation across various organizations in a standard format. Also, technological advancements in voice and text analytics help convert important points and recordings to well-structured and managed digital formats. With digitalization of data, organizations are trending to bring about integration across various technology systems. For instance, the clinical trial data of pharmaceutical firms is being integrated with pharmacovigilance (PV) data for better analytics.
Market Dynamics:
Market Drivers
1.1 Technological services in Demand
1.2 Big Data Generation in life science sector
1.3 Increased cases of chronic diseases
1.4 Increased need of patient satisfaction and Healthcare data maintenance
1.5 Analytics software demand in Clinical Trial sector
1.6 Increasing usage of software in analysing sales and marketing
1.7 Improvement needed in Data Standardization
Market Restraints
2.1 Lack of experts who know the usage
2.2 Expensive implementation of technology
Market Segmentation:
Life Science AnalyticsMarket is segmented on the basis of:
Life Science Analytics Market, by type:
1.1 Descriptive analytics
1.2 Predictive Analytics
1.3 Prescriptive Analytics
>> Click here to Download Sample PDF illustration: http://bit.ly/2CBpcoF
About Us:
Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more Expert concerns.
Contact Us:
sales@kminsights.com
+1 (888) 278-7681
“ By Type (Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, SCM), Component (Software, Service), Delivery (on premise, cloud) and End user (Pharmaceutical, Biotechnology, Medical Device, CRO), and Region (North America, Asia Pacific, Europe, Latin America, Rest of the World) Market Size, Status and Forecast to 2025.”
Market Definition:
Life science analytics software is majorly utilized by Pharmaceutical companies because of them facing unpredictable demands, depleting operating margins and increasing regulatory scrutiny. Inadequate visibility across the supply chain is hampering optimal performance as global sourcing increases the risk of longer lead times.
The growing complexity of operations results in the need to increase agility by improving supply chain visibility. Life science analytics provides the solution for the rising demands and management.
Companies Profiled in this report includes:IBM Corporation (U.S.), Oracle Corporation (U.S.), Quintiles, Inc. (U.S.), Accenture (Ireland), Cognizant (U.S.), Wipro Limited (India), MaxisIT, Inc. (U.S.), TAKE Solutions (India), and SCIO Health Analytics (U.S.).
>> Click here to Download Sample PDF illustration: http://bit.ly/2CBpcoF
Life science institutes and industries are adopting digital records due to their ease of integration, higher standardization, sophistication, and minimized errors. For instance, the health care industry is moving at a greater pace due to EHR (Electronic Health Records) which follow a standard format. The personal property security (PPSA) regulation influences pharmaceutical industries or firms to bring about easy analysis of market expenditure and competitor data to gain significant insights, as it allows data collation across various organizations in a standard format. Also, technological advancements in voice and text analytics help convert important points and recordings to well-structured and managed digital formats. With digitalization of data, organizations are trending to bring about integration across various technology systems. For instance, the clinical trial data of pharmaceutical firms is being integrated with pharmacovigilance (PV) data for better analytics.
Market Dynamics:
Market Drivers
1.1 Technological services in Demand
1.2 Big Data Generation in life science sector
1.3 Increased cases of chronic diseases
1.4 Increased need of patient satisfaction and Healthcare data maintenance
1.5 Analytics software demand in Clinical Trial sector
1.6 Increasing usage of software in analysing sales and marketing
1.7 Improvement needed in Data Standardization
Market Restraints
2.1 Lack of experts who know the usage
2.2 Expensive implementation of technology
Market Segmentation:
Life Science AnalyticsMarket is segmented on the basis of:
Life Science Analytics Market, by type:
1.1 Descriptive analytics
1.2 Predictive Analytics
1.3 Prescriptive Analytics
>> Click here to Download Sample PDF illustration: http://bit.ly/2CBpcoF
About Us:
Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more Expert concerns.
Contact Us:
sales@kminsights.com
+1 (888) 278-7681
Contact Information:
Key Market Insights
sambit kumar
Tel: 8007533694
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Key Market Insights
sambit kumar
Tel: 8007533694
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results